Literature DB >> 28474977

Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Burcu Zeydan1, Val J Lowe2, Christopher G Schwarz2, Scott A Przybelski3, Nirubol Tosakulwong3, Samantha M Zuk2, Matthew L Senjem4, Jeffrey L Gunter5, Rosebud O Roberts6, Michelle M Mielke6, Eduardo E Benarroch7, Moses Rodriguez7, Mary M Machulda8, Timothy G Lesnick3, David S Knopman7, Ronald C Petersen7, Clifford R Jack2, Kejal Kantarci2, Orhun H Kantarci7.   

Abstract

BACKGROUND: There is growing interest in white matter (WM) imaging with positron emission tomography (PET).
OBJECTIVES: We studied the association of cognitive function in late multiple sclerosis (MS) with cortical and WM Pittsburgh compound-B PET (PiB-PET) binding.
METHODS: In the population-based Mayo Clinic Study of Aging, 24 of 4869 participants had MS (12 underwent PiB-PET). Controls were age and sex matched (5:1). We used automated or semi-automated processing for quantitative image analyses and conditional logistic regression for group differences.
RESULTS: MS patients had lower memory ( p = 0.03) and language ( p = 0.02) performance; smaller thalamic volumes ( p = 0.003); and thinner temporal ( p = 0.001) and frontal ( p = 0.045) cortices on magnetic resonance imaging (MRI) than controls. There was no difference in global cortical PiB standardized uptake value ratios between MS and controls ( p = 0.35). PiB uptake was lower in areas of WM hyperintensities compared to normal-appearing white matter (NAWM) in MS ( p = 0.0002). Reduced PiB uptake in both the areas of WM hyperintensities ( r = 0.65; p = 0.02) and NAWM ( r = 0.69; p = 0.01) was associated with decreased visuospatial performance in MS.
CONCLUSION: PiB uptake in the cortex in late MS is not different from normal age-matched controls. PiB uptake in the WM in late MS may be a marker of the large network structures' integrity such as those involved in visuospatial performance.

Entities:  

Keywords:  PET; Pittsburgh compound-B; cognition; multiple sclerosis; myelin; thalamus

Mesh:

Substances:

Year:  2017        PMID: 28474977      PMCID: PMC5665724          DOI: 10.1177/1352458517707346

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  41 in total

1.  Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.

Authors:  Carla Tortorella; Alessandra Bellacosa; Damiano Paolicelli; Aurora Fuiani; Elisabetta Di Monte; Isabella Laura Simone; Patrizia Giaquinto; Paolo Livrea; Maria Trojano
Journal:  J Neurol Sci       Date:  2005-10-04       Impact factor: 3.181

2.  Reduced retention of Pittsburgh compound B in white matter lesions.

Authors:  Lidia Glodzik; Henry Rusinek; Jinyu Li; Cyrus Zhou; Wai Tsui; Lisa Mosconi; Yi Li; Ricardo Osorio; Schantel Williams; Catherine Randall; Nicole Spector; Pauline McHugh; John Murray; Elizabeth Pirraglia; Shankar Vallabhajolusa; Mony de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-21       Impact factor: 9.236

3.  Thalamic neurodegeneration in multiple sclerosis.

Authors:  Alberto Cifelli; Marzena Arridge; Peter Jezzard; Margaret M Esiri; Jacqueline Palace; Paul M Matthews
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

4.  Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

Authors:  Bruno Stankoff; Leorah Freeman; Marie-Stéphane Aigrot; Audrey Chardain; Frédéric Dollé; Anna Williams; Damien Galanaud; Lucie Armand; Stéphane Lehericy; Catherine Lubetzki; Bernard Zalc; Michel Bottlaender
Journal:  Ann Neurol       Date:  2011-02-18       Impact factor: 10.422

5.  Cognitive impairment in probable multiple sclerosis.

Authors:  A Achiron; Y Barak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

6.  Thalamic atrophy and cognition in multiple sclerosis.

Authors:  M K Houtchens; R H B Benedict; R Killiany; J Sharma; Z Jaisani; B Singh; B Weinstock-Guttman; C R G Guttmann; R Bakshi
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

7.  Connecting white matter injury and thalamic atrophy in clinically isolated syndromes.

Authors:  Roland G Henry; Mason Shieh; Bagrat Amirbekian; SungWon Chung; Darin T Okuda; Daniel Pelletier
Journal:  J Neurol Sci       Date:  2009-04-23       Impact factor: 3.181

8.  Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women.

Authors:  Limor Raz; M Jayachandran; Nirubol Tosakulwong; Timothy G Lesnick; Samantha M Wille; Matthew C Murphy; Matthew L Senjem; Jeffrey L Gunter; Prashanthi Vemuri; Clifford R Jack; Virginia M Miller; Kejal Kantarci
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Quantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography.

Authors:  Mattia Veronese; Benedetta Bodini; Daniel García-Lorenzo; Marco Battaglini; Salvatore Bongarzone; Claude Comtat; Michel Bottlaender; Bruno Stankoff; Federico E Turkheimer
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200

View more
  21 in total

1.  A new frontier for amyloid PET imaging: multiple sclerosis.

Authors:  Silvia Morbelli; Matteo Bauckneht; Selene Capitanio; Matteo Pardini; Luca Roccatagliata; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-15       Impact factor: 9.236

2.  White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition.

Authors:  Val J Lowe; Emily S Lundt; Matthew L Senjem; Christopher G Schwarz; Hoon-Ki Min; Scott A Przybelski; Kejal Kantarci; David Knopman; Ronald C Petersen; Clifford R Jack
Journal:  J Nucl Med       Date:  2018-04-19       Impact factor: 10.057

3.  Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.

Authors:  Sylvain Auvity; Matteo Tonietto; Fabien Caillé; Benedetta Bodini; Michel Bottlaender; Nicolas Tournier; Bertrand Kuhnast; Bruno Stankoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-04       Impact factor: 9.236

4.  Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.

Authors:  Alexis Moscoso; Michel J Grothe; Michael Schöll
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-21       Impact factor: 9.236

5.  Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis.

Authors:  Diana P Londoño; Kogulavadanan Arumaithurai; Eleni Constantopoulos; Michael R Basso; R Ross Reichard; Eoin P Flanagan; B Mark Keegan
Journal:  Brain Commun       Date:  2022-06-22

Review 6.  Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.

Authors:  Hsueh-Sheng Chiang; Alka Khera; Barbara E Stopschinski; Olaf Stuve; John Hart; Brendan Kelley; Trung Nguyen
Journal:  Geriatrics (Basel)       Date:  2022-06-05

7.  Comparison of 11C-Pittsburgh Compound B and 18F-Flutemetamol White Matter Binding in PET.

Authors:  Burcu Zeydan; Christopher G Schwarz; Scott A Przybelski; Timothy G Lesnick; Walter K Kremers; Matthew L Senjem; Orhun H Kantarci; Paul H Min; Bradley J Kemp; Clifford R Jack; Kejal Kantarci; Val J Lowe
Journal:  J Nucl Med       Date:  2021-12-16       Impact factor: 11.082

8.  Evaluation of Myelin Radiotracers in the Lysolecithin Rat Model of Focal Demyelination: Beware of Pitfalls!

Authors:  Min Zhang; Gaëlle Hugon; Caroline Bouillot; Radu Bolbos; Jean-Baptiste Langlois; Thierry Billard; Frédéric Bonnefoi; Biao Li; Luc Zimmer; Fabien Chauveau
Journal:  Contrast Media Mol Imaging       Date:  2019-05-29       Impact factor: 3.161

9.  Investigation of white matter PiB uptake as a marker of white matter integrity.

Authors:  Burcu Zeydan; Christopher G Schwarz; Val J Lowe; Robert I Reid; Scott A Przybelski; Timothy G Lesnick; Walter K Kremers; Matthew L Senjem; Jeffrey L Gunter; Hoon-Ki Min; Prashanthi Vemuri; David S Knopman; Ronald C Petersen; Clifford R Jack; Orhun H Kantarci; Kejal Kantarci
Journal:  Ann Clin Transl Neurol       Date:  2019-03-03       Impact factor: 4.511

Review 10.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.